Clinical Microbiology Overview

Principles

Definition

Clinical microbiology is a specialized field within both microbiology and clinical medicine focused on the study of microorganisms that cause disease in humans. It encompasses the isolation, identification, characterization, and susceptibility testing of pathogens from clinical specimens to guide diagnosis, treatment, and prevention strategies for infectious diseases.

Ontological type

Core Methods

Diagnostic Workflows

Clinical Integration

Key developments

Key Figures

Phenotypic Diagnostics and Standardization era

Thomas A. Stamey [1] was a key figure in phenotypic diagnostic standardization during this era, with affiliations at Stanford University [3] and Johns Hopkins University [4]. His contributions are exemplified by the 1965 paper THE LOCALIZATION AND TREATMENT OF URINARY TRACT INFECTIONS: THE ROLE OF BACTERICIDAL URINE LEVELS AS OPPOSED TO SERUM LEVELS [7], which advanced site-specific infection assessment and reinforced standardized biochemical-phenotypic approaches critical to clinical decision-making in the era. Maxwell Finland [2] was associated with Harvard University [5] and Boston University [6] during this period. His 1959 paper OCCURRENCE OF SERIOUS BACTERIAL INFECTIONS SINCE INTRODUCTION OF ANTIBACTERIAL AGENTS [8] highlighted how antibiotic use reshaped infection patterns and underscored the need for standardized reporting, susceptibility testing, and taxonomic frameworks that defined the era.

Hospital Resistance and Epidemiology era

Rudolf Amann [1] is a leading figure in clinical microbiology who held positions at Harvard University [3] and the University of Oregon [4] during the Hospital Resistance and Epidemiology era (1970-1999). In 1999, Amann co-authored The Domain-specific Probe EUB338 is Insufficient for the Detection of all Bacteria: Development and Evaluation of a more Comprehensive Probe Set [7], a key methodological contribution that expanded the repertoire of bacteria-detecting probes and underpinned culture-independent diagnostics vital to hospital surveillance. Michael Wagner [2] is a prominent microbiologist who worked at Northwestern University [5] and the University of Freiburg [6] in this era. Wagner contributed to the same 1999 probe-set study [7], illustrating how expanded probe sets enhance rapid, accurate detection of bacterial taxa in clinical settings and support nosocomial surveillance and infection control.

Genomic Surveillance and Molecular Epidemiology era

Jianwei Wang [1] is a researcher whose work in this era is associated with the University of California, Los Angeles [3] and Cornell University [4]. The paper 'Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China' [7] documented early clinical characteristics of SARS‑CoV‑2 infection, informing diagnosis, triage, and outbreak response in the Genomic Surveillance and Molecular Epidemiology era. Kwok‑Yung Yuen [2] is a scholar whose work in this era is associated with Stanford University [5] and Université Paris‑Sud [6]. The paper 'Clinical Characteristics of Coronavirus Disease 2019 in China' [8] offered early clinical portraits of COVID‑19 and underscored the importance of integrating clinical, genomic, and epidemiologic data to guide surveillance and public health decisions.